News tagged with naltrexone
Certain populations may benefit most from alcohol-dependence treatment naltrexone
Naltrexone is one of the most effective pharmacological treatments for alcohol dependence. However, naltrexone does not work for everyone. A new study has found that naltrexone is effective for women, and individuals with ...
Mar 15, 2011 |
not rated yet |
0
Alcoholics can curb drinking with use of a pill
A little-used medication can help treat alcoholism, an updated review of studies confirms.
Dec 15, 2010 |
4 / 5 (1) |
0
FDA panel recommends approval for Contrave
A Food and Drug Administration panel on Tuesday recommended that the agency approve Orexigen Therapeutics Inc.'s weight loss drug Contrave, making it the first in group of competitors to get a positive nod from experts.
Medicine & Health / Medications
Dec 08, 2010 |
not rated yet |
0
Acamprosate prevents relapse to drinking in alcoholism
Acamprosate reduces the number of patients being treated for alcoholism who return to drinking, according to a new Cochrane Systematic Review. The drug showed moderate benefits in trials when used in addition to non-drug treatm ...
Medicine & Health / Medications
Sep 08, 2010 |
4 / 5 (1) |
1
Combination treatment for obesity leads to substantial reductions in body weight
Combination treatment for obesity using the drugs naltrexone and bupropion, plus diet and exercise, helps reduce bodyweight by a mean of 5% or more over a year, depending on the dosage used. The findings of the COR-I study ...
Jul 29, 2010 |
not rated yet |
2
Men and women respond equally to naltrexone as treatment for alcohol dependence
While the prevalence of alcohol use disorders (AUDs) in the United States during the 1980s was roughly five times more common among men than women, the gap between the genders has narrowed: AUDs are now only twice as prevalent ...
Medicine & Health / Medical research
Jul 20, 2010 |
not rated yet |
0
Opioid-blocking medication reduces brain's response to alcoholism cues
Researchers at Harvard-affiliated McLean Hospital have produced the first evidence that the opioid blocker extended-release injectable naltrexone (XR-NTX) is able to reduce the brain's response to cues that may cause alcoholics ...
Medicine & Health / Medical research
May 26, 2010 |
5 / 5 (2) |
0
Oral naltrexone can reduce health care costs
Alcohol-use disorders (AUDs), referring to both alcohol abuse and alcohol dependence, affect nearly 8.5 percent of the American population, are associated with numerous medical, psychiatric, family, legal, and work-related ...
Apr 05, 2010 |
4 / 5 (1) |
1
Pathological gambling may be successfully treated with medications for substance addiction
Pathological gambling can be successfully treated with medications that decrease urges and increase inhibitions, according to researchers at the annual meeting of the American College of Neuropsychopharmacology (ACNP). Researchers ...
Medicine & Health / Psychology & Psychiatry
Dec 10, 2009 |
5 / 5 (1) |
0
Suppressing the compulsion to steal: Opiate receptor blocker shows promise in treating kleptomania
If a drug took the fun out of stealing, would it reduce crime? A new study scheduled for the April 1st issue of Biological Psychiatry, published by Elsevier, suggests that this may be so.
Medicine & Health / Medical research
Apr 01, 2009 |
not rated yet |
0
Naltrexone can help heavy social drinkers quit smoking
Naltrexone, an opioid antagonist approved in 1994 by the U.S. Food and Drug Administration for alcohol-dependence (AD) treatment, can reduce relapse rates among AD patients. Research on naltrexone's effectiveness on nicotine ...
Mar 19, 2009 |
not rated yet |
0
Naltrexone
Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. It is marketed in generic form as its hydrochloride salt, naltrexone hydrochloride, and marketed under the trade names Revia and Depade. In some countries including the United States, a once-monthly extended-release injectable formulation is marketed under the trade name Vivitrol. Also in the US, Methylnaltrexone Bromide, a closely related drug, is marketed as Relistor, for the treatment of opioid induced constipation.
Naltrexone should not be confused with naloxone (which is used in emergency cases of overdose rather than for longer-term dependence control) nor nalorphine. Both nalorphine and naloxone are full antagonists and will treat an opioid overdose, but naltrexone is longer-acting than naloxone (although neither is an irreversible antagonist like naloxazone), making naloxone a better emergency antidote.
For more information about Naltrexone, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
